These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16842404)

  • 1. The effect of the CYP2C19*2 heterozygote genotype on the pharmacokinetics of nelfinavir.
    Burger DM; Schwietert HR; Colbers EP; Becker M
    Br J Clin Pharmacol; 2006 Aug; 62(2):250-2. PubMed ID: 16842404
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
    Hirt D; Mentré F; Tran A; Rey E; Auleley S; Salmon D; Duval X; Tréluyer JM;
    Br J Clin Pharmacol; 2008 Apr; 65(4):548-57. PubMed ID: 17922881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease.
    Khaliq Y; Gallicano K; Seguin I; Fyke K; Carignan G; Bulman D; Badley A; Cameron DW
    Br J Clin Pharmacol; 2000 Aug; 50(2):108-15. PubMed ID: 10930962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19.
    Hirani VN; Raucy JL; Lasker JM
    Drug Metab Dispos; 2004 Dec; 32(12):1462-7. PubMed ID: 15448116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite.
    Damle BD; Uderman H; Biswas P; Crownover P; Lin C; Glue P
    Br J Clin Pharmacol; 2009 Nov; 68(5):682-9. PubMed ID: 19916992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy.
    Saitoh A; Capparelli E; Aweeka F; Sarles E; Singh KK; Kovacs A; Burchett SK; Wiznia A; Nachman S; Fenton T; Spector SA
    J Acquir Immune Defic Syndr; 2010 Jul; 54(3):285-9. PubMed ID: 19890215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study.
    Damle B; Fosser C; Ito K; Tran A; Clax P; Uderman H; Glue P
    J Clin Pharmacol; 2009 Mar; 49(3):291-300. PubMed ID: 19246729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose of proton pump inhibitors and the CYP2C19 genotype.
    Bertilsson L
    Basic Clin Pharmacol Toxicol; 2004 Jul; 95(1):1. PubMed ID: 15245568
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progress in the studies on the CYP2C19 polymorphism].
    He N; Zhou HH
    Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):171-4. PubMed ID: 12889158
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?
    Bramness JG; Skurtveit S; Fauske L; Grung M; Molven A; Mørland J; Steen VM
    Pharmacogenetics; 2003 Jul; 13(7):383-8. PubMed ID: 12835613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism.
    Chen MC; Hu CT; Wang LY; Lin HH
    Aliment Pharmacol Ther; 2005 Aug; 22(3):274-5; author reply 275-6. PubMed ID: 16091067
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment on Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients.
    Merry C
    AIDS; 2001 May; 15(8):1057-8. PubMed ID: 11399989
    [No Abstract]   [Full Text] [Related]  

  • 13. Single nucleotide polymorphism genotyping of CYP2C19 using a new automated system.
    Matsumoto N; Kakihara F; Kimura S; Kurebayashi Y; Hirai M; Yohda M; Hasegawa S
    Anal Biochem; 2007 Nov; 370(1):121-3. PubMed ID: 17603002
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status.
    Ikeda Y; Umemura K; Kondo K; Sekiguchi K; Miyoshi S; Nakashima M
    Clin Pharmacol Ther; 2004 Jun; 75(6):587-8. PubMed ID: 15179414
    [No Abstract]   [Full Text] [Related]  

  • 15. Rabeprazole experience in Korea; focus on CYP2C19 polymorphism.
    Park SH
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S20-1. PubMed ID: 16359345
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Inaba T; Yamamoto K; Okada H; Yokota K; Oguma K; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2403-8. PubMed ID: 14638340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C19 polymorphisms in patients with gastric and colorectal carcinoma.
    Tamer L; Ercan B; Ercan S; Ateş N; Ateş C; Ocal K; Dirlik M; Aydin S; Atik U
    Int J Gastrointest Cancer; 2006; 37(1):1-5. PubMed ID: 17290075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxylation of lansoprazole in poor metabolizers of CYP2C19.
    Furuta T; Shirai N; Sugimoto M; Nakamura A; Hishida A
    Br J Clin Pharmacol; 2006 Mar; 61(3):361; author reply 361-2. PubMed ID: 16487234
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interluekin-1 beta genetic polymorphism influences the impact of cytochrome P 2C19 genotype on the cure rate of H. pylori eradication therapy].
    Mizuno M; Take S; Ishiki K; Okada H; Shiratori Y
    Nihon Rinsho; 2004 Mar; 62(3):455-8. PubMed ID: 15038086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibility to antibiotics and drug metabolism in patients with H. pylori infection refractory to the initial treatment--therapeutic strategy based on susceptibility to CAM and CYP2C19 polymorphism].
    Furuta T; Sugimoto M; Nakamura A; Shirai N
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():426-33. PubMed ID: 16363573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.